Evidence map›Paper›PMID 38875527›Full record

ArticleACS nano2024

Nanopores Reveal the Stoichiometry of Single Oligoadenylates Produced by Type III CRISPR-Cas.

David Fuentenebro Navas, Jurre A Steens, Carlos de Lannoy, Ben Noordijk, Michael Pfeffer, Dick de Ridder, Raymond H. J. Staals, Sonja Schmid

Abstract read
In one paragraph

Article in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David Fuentenebro NavasLaboratory of Biophysics, Wageningen University and Research, Stippeneng 4, 6708WE Wageningen, The Netherlands.
Jurre A SteensLaboratory of Microbiology, Wageningen University and Research, Stippeneng 4, 6708WE Wageningen, The Netherlands.
Carlos de LannoyBioinformatics Group, Wageningen University and Research, Droevendaalsesteeg 1, 6708PB Wageningen, The Netherlands.ORCID 0000-0002-3754-0508
Ben NoordijkBioinformatics Group, Wageningen University and Research, Droevendaalsesteeg 1, 6708PB Wageningen, The Netherlands.
Michael PfefferDepartment of Chemistry, University of Basel, Mattenstrasse 22, 4058 Basel, Switzerland.
Dick de RidderBioinformatics Group, Wageningen University and Research, Droevendaalsesteeg 1, 6708PB Wageningen, The Netherlands.
Raymond H. J. StaalsLaboratory of Microbiology, Wageningen University and Research, Stippeneng 4, 6708WE Wageningen, The Netherlands.
Sonja SchmidLaboratory of Biophysics, Wageningen University and Research, Stippeneng 4, 6708WE Wageningen, The Netherlands.ORCID 0000-0002-3710-5602

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic oligoadenylates (cOAs) are small second messenger molecules produced by the type III CRISPR-Cas system as part of the prokaryotic immune response. The role of cOAs is to allosterically activate downstream effector proteins that induce dormancy or cell death, and thus abort viral spread through the population. Interestingly, different type III systems have been reported to utilize different cOA stoichiometries (with 3 to 6 adenylate monophosphates). However, so far, their characterization has only been possible in bulk and with sophisticated equipment, while a portable assay with single-molecule resolution has been lacking. Here, we demonstrate the label-free detection of single cOA molecules using a simple protein nanopore assay. It sensitively identifies the stoichiometry of individual cOA molecules and their mixtures from synthetic and enzymatic origin. To achieve this, we trained a convolutional neural network (CNN) and validated it with a series of experiments on mono- and polydisperse cOA samples. Ultimately, we determined the stoichiometric composition of cOAs produced enzymatically by the CRISPR type III-A and III-B variants of

Indexed as

CRISPR-Cas SystemsNanoporesCRISPR-Casnanoporeneural networksecond messengersingle-molecule detectiontype III

Identifiers

PMID38875527
PMCPMC11223493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.